| |
| |
|
| Insider
Information: |
Crooke Stanley T |
| Relationship: |
Director, 10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
2,021 |
|
|
Indirect Shares
|
7,547,002 |
|
|
| Direct
Value |
$75,929 |
|
|
|
Indirect Value
|
$34,834,505 |
|
|
| Total
Shares |
7,549,023 |
|
|
| Total
Value |
$34,910,434 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
Exec Chairman of the B... |
2021-01-26 |
2,021 |
2021-01-26 |
497,502 |
Premium* |
|
|
Regulus Therapeutics Inc. |
RGLS |
Director, 10% Owner |
2012-10-10 |
0 |
2012-10-10 |
7,049,500 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
463 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 19
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2012-10-10 |
4 |
A |
$0.00 |
$0 |
I/I |
6,299,500 |
6,299,500 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, CEO and President |
• • – |
2013-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,978 |
2,978 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, CEO and President |
• • – |
2013-01-15 |
4 |
OE |
$0.00 |
$0 |
I/I |
317 |
317 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2014-01-15 |
4 |
OE |
$0.00 |
$0 |
I/I |
734 |
748 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2014-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,526 |
8,075 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2015-01-15 |
4 |
OE |
$0.00 |
$0 |
I/I |
1,087 |
1,433 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2015-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,338 |
18,772 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2016-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,212 |
28,827 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2016-01-15 |
4 |
OE |
$0.00 |
$0 |
I/I |
1,449 |
2,315 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-01-15 |
4 |
OE |
$0.00 |
$0 |
I/I |
1,467 |
3,193 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
28,367 |
42,424 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2018-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,612 |
67,626 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2018-01-15 |
4 |
OE |
$0.00 |
$0 |
I/I |
1,722 |
4,784 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2019-01-15 |
4 |
OE |
$0.00 |
$0 |
I/I |
2,346 |
6,474 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2019-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
30,587 |
82,320 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Executive Chairman of Board |
• • – |
2020-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
39,643 |
109,277 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Executive Chairman of Board |
• • – |
2020-01-15 |
4 |
OE |
$0.00 |
$0 |
I/I |
3,317 |
8,849 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Exec Chairman of the Board |
• • – |
2021-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
47,257 |
49,278 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Exec Chairman of the Board |
• • – |
2021-01-15 |
4 |
OE |
$0.00 |
$0 |
I/I |
4,371 |
4,545 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, CEO and President |
• • – |
2013-01-16 |
4 |
S |
$14.00 |
$2,002 |
I/I |
(143) |
174 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-04-19 |
4 |
OE |
$7.25 |
$3,625 |
I/I |
500 |
3,562 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President, CEO |
• • – |
2004-01-22 |
4 |
AS |
$8.19 |
$4,095 |
D/D |
(500) |
944,241 |
|
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2016-01-05 |
4 |
OE |
$9.22 |
$4,610 |
I/I |
500 |
1,797 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President, CEO |
• • – |
2004-11-29 |
4 |
OE |
$4.00 |
$6,196 |
D/D |
1,549 |
923,790 |
|
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President, CEO |
• • – |
2011-12-19 |
4 |
OE |
$5.80 |
$6,380 |
I/I |
1,100 |
982 |
0 |
- |
|
463 Records found
|
|
Page 1 of 19 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
